10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0000874716-14-000011`
Period End Date	20140930
Filing Date	20141024
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	idxx-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 88 Cash Flow Statement 68 Comprehensive Income 52

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.18M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$3.53M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$264.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$223.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$292.74M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Accounts receivable, net of reserves of $4,182 in 2014 and $3,533 in 2013	`AccountsReceivableNetCurrent`	$160.47M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.19M	shares	Point-in-time
Accounts receivable, net of reserves of $4,182 in 2014 and $3,533 in 2013	`AccountsReceivableNetCurrent`	$158.04M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.70M	shares	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	123,000.00	shares	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	122,000.00	shares	Point-in-time
Inventories	`InventoryNet`	$156.01M	USD	Point-in-time
Inventories	`InventoryNet`	$133.43M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	49.65M	shares	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$33.26M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	53.44M	shares	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$33.23M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$60.15M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.96M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$652.71M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$702.62M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$281.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$291.70M	USD	Point-in-time
Goodwill	`Goodwill`	$180.52M	USD	Point-in-time
Goodwill	`Goodwill`	$176.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$58.84M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$59.21M	USD	Point-in-time
Other long-term assets, net	`OtherAssetsNoncurrent`	$57.23M	USD	Point-in-time
Other long-term assets, net	`OtherAssetsNoncurrent`	$60.56M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$588.01M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$577.81M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.29B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.23B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$58.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$29.94M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$148.92M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$167.45M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$375.00M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$277.00M	USD	Point-in-time
Current portion of long-term debt	`SecuredDebtCurrent`	$1.03M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$29.56M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$21.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$478.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$630.26M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$27.76M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$33.95M	USD	Point-in-time
Long-term debt, net of current portion	`SecuredLongTermDebt`	$150.36M	USD	Point-in-time
Long-term debt, net of current portion	`SecuredLongTermDebt`	$350.00M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$21.55M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$18.43M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$31.59M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$31.21M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$430.90M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$233.95M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.06B	USD	Point-in-time
Total liabilities	`Liabilities`	$712.30M	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value per share: Authorized: 120,000 shares; Issued: 101,704 and 101,188 shares in 2014 and 2013, respectively	`CommonStockValue`	$10.17M	USD	Point-in-time
Common stock, $0.10 par value per share: Authorized: 120,000 shares; Issued: 101,704 and 101,188 shares in 2014 and 2013, respectively	`CommonStockValue`	$10.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$866.21M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$825.32M	USD	Point-in-time
Deferred stock units: Outstanding: 123 and 122 units in 2014 and 2013, respectively	`CommonStockOtherValueOutstanding`	$5.11M	USD	Point-in-time
Deferred stock units: Outstanding: 123 and 122 units in 2014 and 2013, respectively	`CommonStockOtherValueOutstanding`	$5.25M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.49B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.65B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.99M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$13.62M	USD	Point-in-time
Treasury stock, at cost: 53,436 and 49,649 shares in 2014 and 2013, respectively	`TreasuryStockValue`	$2.30B	USD	Point-in-time
Treasury stock, at cost: 53,436 and 49,649 shares in 2014 and 2013, respectively	`TreasuryStockValue`	$1.83B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders' equity	`StockholdersEquity`	$229.39M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders' equity	`StockholdersEquity`	$518.19M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$83.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$28.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$518.21M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.23B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.29B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	$206.69M	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$629.78M	USD	3 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$690.57M	USD	3 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$233.67M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$131.60M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$393.20M	USD	3 Qtrs
Service revenue	`SalesRevenueServicesNet`	$443.27M	USD	3 Qtrs
Service revenue	`SalesRevenueServicesNet`	$149.86M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$338.30M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$383.52M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.13B	USD	3 Qtrs
Total revenue	`SalesRevenueNet`	$1.02B	USD	3 Qtrs
Cost of product revenue	`CostOfGoodsSold`	$76.52M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$230.51M	USD	3 Qtrs
Cost of product revenue	`CostOfGoodsSold`	$249.78M	USD	3 Qtrs
Cost of product revenue	`CostOfGoodsSold`	$84.78M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$85.40M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$250.12M	USD	3 Qtrs
Cost of service revenue	`CostOfServices`	$75.99M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$225.02M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$499.90M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$455.53M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$170.19M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$152.51M	USD	1 Quarter
Gross profit	`GrossProfit`	$567.45M	USD	3 Qtrs
Gross profit	`GrossProfit`	$633.95M	USD	3 Qtrs
Gross profit	`GrossProfit`	$213.34M	USD	1 Quarter
Gross profit	`GrossProfit`	$185.78M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$70.60M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$60.08M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$179.64M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$206.47M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$45.70M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$38.65M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$116.87M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$128.63M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$73.39M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$21.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$65.51M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$24.85M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$65.48M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$225.45M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$72.19M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$205.43M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.46M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.29M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.48M	USD	3 Qtrs
Interest expense	`InterestExpense`	$10.03M	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$1.27M	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$1.34M	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$313.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$456.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$68.21M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$216.69M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$203.30M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$64.48M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$58.74M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$16.05M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$60.69M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$18.79M	USD	1 Quarter
Net income	`ProfitLoss`	$156.00M	USD	3 Qtrs
Net income	`ProfitLoss`	$52.16M	USD	1 Quarter
Net income	`ProfitLoss`	$45.69M	USD	1 Quarter
Net income	`ProfitLoss`	$144.56M	USD	3 Qtrs
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00K	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$15.00K	USD	3 Qtrs
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$55.00K	USD	3 Qtrs
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$21.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$52.14M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$45.69M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$144.54M	USD	3 Qtrs
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$155.94M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$3.07	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$1.05	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$2.70	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.87	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.86	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$3.03	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$2.66	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$1.03	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	49.74M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	53.56M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	50.82M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	52.45M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	53.24M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.40M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.39M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.52M	shares	3 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$156.00M	USD	3 Qtrs
Net income	`ProfitLoss`	$52.16M	USD	1 Quarter
Net income	`ProfitLoss`	$45.69M	USD	1 Quarter
Net income	`ProfitLoss`	$144.56M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$41.13M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$43.61M	USD	3 Qtrs
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$1.68M	USD	3 Qtrs
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$1.23M	USD	3 Qtrs
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-984.00K	USD	3 Qtrs
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-6.73M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$13.46M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$12.27M	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$446.00K	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-79.00K	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$7.44M	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$9.58M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$8.46M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$12.79M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$10.22M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$12.64M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.38M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-4.72M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$6.88M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$3.96M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$16.22M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-335.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$4.05M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$11.57M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$208.54M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$180.58M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$42.50M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$61.46M	USD	3 Qtrs
Proceeds from disposition of pharmaceutical product lines	`ProceedsFromSaleOfOtherProductiveAssets`	$3.50M	USD	3 Qtrs
Proceeds from sale of equity investment	`EquityMethodInvestmentNetSalesProceeds`	$-5.40M	USD	3 Qtrs
Acquisitions of intangible assets	`PaymentsToAcquireIntangibleAssets`	$1.02M	USD	3 Qtrs
Acquisitions of intangible assets	`PaymentsToAcquireIntangibleAssets`	$175.00K	USD	3 Qtrs
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.52M	USD	3 Qtrs
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.10M	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.08M	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.80M	USD	3 Qtrs
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$98.00M	USD	3 Qtrs
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$185.20M	USD	3 Qtrs
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$200.00M	USD	3 Qtrs
Debt issue costs	`DebtIssuanceCosts`	$-1.36M	USD	3 Qtrs
Payment of notes payable	`RepaymentsOfSecuredDebt`	$1.39M	USD	3 Qtrs
Payment of notes payable	`RepaymentsOfSecuredDebt`	$858.00K	USD	3 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$282.91M	USD	3 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$468.97M	USD	3 Qtrs
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$21.73M	USD	3 Qtrs
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$18.36M	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$7.44M	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$9.58M	USD	3 Qtrs
Net cash (used) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-69.40M	USD	3 Qtrs
Net cash (used) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-145.78M	USD	3 Qtrs
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.28M	USD	3 Qtrs
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-4.29M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$40.83M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$13.68M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$264.81M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$223.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$292.74M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$264.81M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$223.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$292.74M	USD	Point-in-time
Market value of common shares received from employees in connection with share-based compensation - see Note 18	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.30M	USD	3 Qtrs
Market value of common shares received from employees in connection with share-based compensation - see Note 18	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.30M	USD	3 Qtrs

Comprehensive Income 52 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$156.00M	USD	3 Qtrs
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-19.00K	USD	3 Qtrs
Net income	`ProfitLoss`	$52.16M	USD	1 Quarter
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$51.00K	USD	1 Quarter
Net income	`ProfitLoss`	$45.69M	USD	1 Quarter
Net income	`ProfitLoss`	$144.56M	USD	3 Qtrs
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-23.00K	USD	1 Quarter
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$84.00K	USD	3 Qtrs
Unrealized (loss) gain, tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$2.81M	USD	1 Quarter
Unrealized (loss) gain, tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$1.28M	USD	3 Qtrs
Unrealized (loss) gain, tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$1.80M	USD	3 Qtrs
Unrealized (loss) gain, tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-1.51M	USD	1 Quarter
Reclassification adjustment for losses (gains) included in net income, tax benefit (expense)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$542.00K	USD	3 Qtrs
Foreign currency translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease`	$9.42M	USD	1 Quarter
Foreign currency translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease`	$-15.52M	USD	3 Qtrs
Reclassification adjustment for losses (gains) included in net income, tax benefit (expense)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$-24.00K	USD	3 Qtrs
Reclassification adjustment for losses (gains) included in net income, tax benefit (expense)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$329.00K	USD	1 Quarter
Foreign currency translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease`	$-19.00M	USD	1 Quarter
Reclassification adjustment for losses (gains) included in net income, tax benefit (expense)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$67.00K	USD	1 Quarter
Foreign currency translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease`	$-2.12M	USD	3 Qtrs
Unrealized (loss) gain on investments, net of tax (benefit) expense of ($23) and ($19) in 2014 and $51 and $84 in 2013	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-32.00K	USD	3 Qtrs
Unrealized (loss) gain on investments, net of tax (benefit) expense of ($23) and ($19) in 2014 and $51 and $84 in 2013	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-37.00K	USD	1 Quarter
Unrealized (loss) gain on investments, net of tax (benefit) expense of ($23) and ($19) in 2014 and $51 and $84 in 2013	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$142.00K	USD	3 Qtrs
Unrealized (loss) gain on investments, net of tax (benefit) expense of ($23) and ($19) in 2014 and $51 and $84 in 2013	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$86.00K	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $2,809 and $1,796 in 2014 and ($1,512) and $1,278 in 2013	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$3.07M	USD	3 Qtrs
Unrealized gain (loss), net of tax expense (benefit) of $2,809 and $1,796 in 2014 and ($1,512) and $1,278 in 2013	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$6.20M	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $2,809 and $1,796 in 2014 and ($1,512) and $1,278 in 2013	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-3.60M	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $2,809 and $1,796 in 2014 and ($1,512) and $1,278 in 2013	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$4.03M	USD	3 Qtrs
Less: reclassification adjustment for gains included in net income, net of tax expense (benefit) of $67 and ($24) in 2014 and $329 and $542 in 2013	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$103.00K	USD	3 Qtrs
Less: reclassification adjustment for gains included in net income, net of tax expense (benefit) of $67 and ($24) in 2014 and $329 and $542 in 2013	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$205.00K	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense (benefit) of $67 and ($24) in 2014 and $329 and $542 in 2013	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$834.00K	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense (benefit) of $67 and ($24) in 2014 and $329 and $542 in 2013	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$1.49M	USD	3 Qtrs
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-4.43M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$1.58M	USD	3 Qtrs
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$3.92M	USD	3 Qtrs
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$6.00M	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$5.07M	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00K	USD	3 Qtrs
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-11.63M	USD	3 Qtrs
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-13.04M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$50.76M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$39.12M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$144.16M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$144.37M	USD	3 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$15.00K	USD	3 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$4.00K	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$21.00K	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$55.00K	USD	3 Qtrs
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$39.10M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$50.76M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$144.31M	USD	3 Qtrs
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$144.15M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.